Up­dat­ed: Phar­ma com­pa­nies present IRA cas­es in New Jer­sey court

TREN­TON — Four phar­ma­ceu­ti­cal com­pa­nies made their case against the In­fla­tion Re­duc­tion Act’s drug ne­go­ti­a­tions pro­vi­sions on Thurs­day, ar­gu­ing that the pro­gram vi­o­lates sev­er­al con­sti­tu­tion­al rights among oth­er items.

Bris­tol My­ers Squibb, No­var­tis, No­vo Nordisk and John­son & John­son’s Janssen gave co­or­di­nat­ed ar­gu­ments in New Jer­sey’s dis­trict court in their cas­es against the gov­ern­ment. The com­pa­nies col­lec­tive­ly mar­ket six of the first 10 drugs that are un­der ne­go­ti­a­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER